Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Plasma-Cell Myeloma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Not Yet RecruitingNCT07732712
What this trial is testing

Isa-VRdlite for of Frail and/or Much Older Patients With High Risk Newly Diagnosed Multiple Myeloma Base on Circulating Plasma Cells

Who this might be right for
Multiple Myeloma
The Affiliated People's Hospital of Ningbo University 15
Testing effectiveness (Phase 2)Study completedNCT01427881
What this trial is testing

Cyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematological Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Megakaryoblastic Leukemia (M7)+65 more
Fred Hutchinson Cancer Center 43
Not applicableEnrolling By InvitationNCT07499128
What this trial is testing

Continuous Temperature Monitoring (CTM) for Cytokine Release Syndrome (CRS), an Immune-Related Adverse Event

Who this might be right for
Cytokine Release SyndromeNeoplasmsLymphoma+13 more
National Cancer Institute (NCI) 136
Not applicableLooking for participantsNCT06252792
What this trial is testing

Dara-PD in the Treatment of Patients With First Relapse of Multiple Myeloma

Who this might be right for
Multiple MyelomaFirst Relapse
FengYan Jin 50
Testing effectiveness (Phase 2)UnknownNCT01328236
What this trial is testing

Bortezomib in Combination With Liposomal Doxorubicin and Dexamethasone to Treat Plasma Cell Leukemia

Who this might be right for
Plasma Cell LeukemiaMultiple Myeloma
Clinical Service, China 20
Testing effectiveness (Phase 2)Study completedNCT00105001
What this trial is testing

Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Myelodysplastic/Myeloproliferative Neoplasm, UnclassifiablePreviously Treated Myelodysplastic SyndromeRefractory Chronic Lymphocytic Leukemia+113 more
Fred Hutchinson Cancer Center 210
Not applicableStudy completedNCT04039100
What this trial is testing

Family Caregiver Ambassador Support for Family Caregivers of Patients With Hematological Disease

Who this might be right for
Multiple MyelomaLymphomaBone Marrow Transplantation+3 more
Rigshospitalet, Denmark 43
Large-scale testing (Phase 3)Ended earlyNCT00522392
What this trial is testing

Bortezomib and Dexamethasone With or Without Lenalidomide in Treating Patients With Multiple Myeloma Previously Treated With Dexamethasone

Who this might be right for
Stage I Multiple MyelomaStage II Multiple MyelomaStage III Multiple Myeloma
National Cancer Institute (NCI) 48
Very early researchUnknownNCT06574958
What this trial is testing

Clinical Study of CD38\CS1 Chimeric Antigen Receptor T Cells in the Treatment of Refractory/Recurrent Multiple Myeloma

Who this might be right for
ORR,OS,PFS
The Second Hospital of Shandong University 10
Not applicableStudy completedNCT05284591
What this trial is testing

Non-interventional Study to Evaluate Patient and Healthcare Provider Satisfaction of Daratumumab Use in the Treatment of First-line Daratumumab, Lenalidomide, Dexamethasone (DRd) Multiple Myeloma Patients in Germany Depending on Application Route (sc or iv)

Who this might be right for
Multiple MyelomaNewly DiagnosedTransplant Ineligible+3 more
iOMEDICO AG 96
Testing effectiveness (Phase 2)Study completedNCT02751255
What this trial is testing

Daratumumab in Combination With ATRA

Who this might be right for
Multiple Myeloma
Amsterdam UMC, location VUmc 60
Testing effectiveness (Phase 2)UnknownNCT05880043
What this trial is testing

GIC-102, Intravenous Allogeneic NK Cells, in Subjects With Advanced Solid Cancers and R/R Hematologic Malignancies

Who this might be right for
Advanced Solid TumorsRelapsed/Refractory Non-Hodgkin LymphomaRelapsed/Refractory Multiple Myeloma
GI Cell, Inc. 50
Testing effectiveness (Phase 2)Looking for participantsNCT05841550
What this trial is testing

The TG01 Study With TG01/QS-21 Vaccine in Patients With High-risk Smouldering Multiple Myeloma and Multiple Myeloma

Who this might be right for
Multiple MyelomaSmoldering Multiple Myeloma
Oslo University Hospital 20
Testing effectiveness (Phase 2)Study completedNCT02219178
What this trial is testing

Study of the Efficacy and Safety of RsqVD Combination Therapy for Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Cancer Trials Ireland 42
Not applicableStudy completedNCT03135925
What this trial is testing

Feasibility of Pre Transplant Exercise (Pre-habilitation) for Multiple Myeloma Patients Awaiting Autologous Stem Cell Transplantation

Who this might be right for
Myeloma
Sheffield Teaching Hospitals NHS Foundation Trust 23
Large-scale testing (Phase 3)Study completedNCT01016548
What this trial is testing

Evaluation of Influenza H1N1 Vaccine in Adults With Lymphoid Malignancies on Chemotherapy

Who this might be right for
LymphomaMultiple MyelomaInfluenza A Virus, H1N1 Subtype
University Health Network, Toronto 42
Post-approval studies (Phase 4)Looking for participantsNCT06251076
What this trial is testing

Plan Development for Giving Teclistamab in the Outpatient Setting

Who this might be right for
Multiple MyelomaRelapsed CancerRefractory Cancer
University Health Network, Toronto 15
Not applicableStudy completedNCT00741455
What this trial is testing

Chemotherapy Followed by Allogeneic Stem Cell Transplantation for Hematologic Malignancies

Who this might be right for
Hematologic Malignancies
Dartmouth-Hitchcock Medical Center 18
Testing effectiveness (Phase 2)Study completedNCT00773838
What this trial is testing

Study of Vorinostat (MK0683), an Histone Deacetylase (HDAC) Inhibitor in Combination With Bortezomib in Patients With Relapsed or Refractory Multiple Myeloma (MK-0683-095)

Who this might be right for
Relapsed or Refractory Multiple Myeloma
Merck Sharp & Dohme LLC 143
Early research (Phase 1)Ended earlyNCT03448978
What this trial is testing

Autologous CD8+ T-cells Expressing an Anti-BCMA CAR in Patients With Myeloma

Who this might be right for
Multiple Myeloma
Cartesian Therapeutics 32
Next Page